Abstract:BACKGROUND Babesiosis infections are infrequent, occur in limited geographic locations, and range from asymptomatic infection to severe illness and death. METHODS Descriptive clinical and epidemiological information on human babesiosis cases was collated from state communicable disease reports and medical records of patients hospitalized from 1982 to 1993. Univariate and multivariate analyses were performed to determine prognostic factors associated with severe disease outcome (hospitalization ending in death, duration of hospitalization > 14 days, or intensive care unit stay > 2 days). RESULTS Between 1982 and 1993, 139 patients were hospitalized with babesiosis in New York State. Nine patients (6.5%) died, 35 (25.2%) were admitted to the intensive care unit, and 35 (25.2%) required hospitalization for more than 14 days. Mean age at first hospitalization was 62.5 years. Sixty-two percent were male, and 91% resided in Suffolk County, Long Island. The most common symptoms were fatigue/malaise/weakness (91%), fever (91%), shaking chills (77%), and diaphoresis (69%). Past medical records showed that 52% of patients had a history of chronic disease; 12% had a history of Lyme disease; 12% had undergone a splenectomy; and 2% had undergone a blood transfusion. There was a 12- to 14-day delay between onset of symptoms and initiation of appropriate antibiotic treatment. Univariate analyses showed alkaline phosphatase levels greater than 125 U/L, white blood cell counts greater than 5 x 10(9)/L, history of cardiac abnormality, history of splenectomy, presence of heart murmur, and parasitemia values of 0.04 or higher to be significantly associated with disease severity. Multiple logistic regression analyses indicated that male sex, alkaline phosphatase values greater than 125 U/L, and white blood cell counts greater than 5 x 10(9)/L remained strong predictors of severe outcome. CONCLUSIONS Human babesiosis is a rare but debilitating and potentially fatal illness, especially in the elderly. Prompt disease diagnosis and treatment are essential but are often delayed, as seen in our series. This delay reinforces the need for enhanced public and physician education targeted toward residents and visitors to the few high-risk geographic areas where disease and Ixodes scapularis ticks are endemic. Patients presenting with certain prognostic indicators (male sex, alkaline phosphatase values > 125 U/L, and white blood cell counts >5 x 10(9)/L) require comprehensive and aggressive medical care to prevent further deterioration. Since babesiosis is only 1 of 3 currently recognized diseases transmitted by I scapularis ticks, primary prevention recommendations will also reduce human exposure to Lyme disease and human granulocytic ehrlichiosis.

Cancerous inhibitor of protein phosphatase 2A is overexpressed in cervical cancer and upregulated by human papillomavirus 16 E7 oncoprotein.

Effects of Human Papillomavirus Type 16 E7 Protein on the Growth of Cervical Carcinoma Cells and Immuno-Escape Through the TGF-β1 Signaling Pathway

Human babesiosis in New York State: Review of 139 hospitalized cases and analysis of prognostic factors.

Primary papillary adenocarcinoma in the third portion of the duodenum.

Cip2a is Associated with Human Breast Cancer Aggressivity

Genome-Wide Profiling of Cervical RNA-Binding Proteins Identifies Human Papillomavirus Regulation of RNASEH2A Expression by Viral E7 and E2F1

Data from CIP2A is Associated with Human Breast Cancer Aggressivity

Expression of CIP2A in clear cell renal cell carcinoma and its clinical significance

HPV18 E6/E7 activates Ca2+ influx to promote the malignant progression of cervical cancer by inhibiting Ca2+ binding protein 1 expression

Transcriptome Sequencing Profiles of Cervical Cancer Tissues and SiHa Cells

Piwil2 is Reactivated by HPV Oncoproteins and Initiates Cell Reprogramming Via Epigenetic Regulation During Cervical Cancer Tumorigenesis.

HPV16 E6-Activated OCT4 Promotes Cervical Cancer Progression by Suppressing P53 Expression Via Co-Repressor NCOR1

Cyclin-dependent Kinase 9 Promotes Cervical Cancer Development Via AKT2/p53 Pathway.

HPV58 E7 Protein Expression Profile in Cervical Cancer and CIN with Immunohistochemistry

[Expression of Cyclin D1 in Cervical Intraepithelial Neoplasia and Squamous Cell Carcinoma and Its Relationship with HPV16 E7 Gene].

A novel function of IMPA2, plays a tumor-promoting role in cervical cancer

[Clinical value of acoustic radiation force impulse imaging for quantitative evaluation of degree of liver fibrosis in chronic hepatitis C patients].

CBP-mediated Wnt3a/β-catenin Signaling Promotes Cervical Oncogenesis Initiated by Piwil2

Human Papillomavirus E7 Oncoprotein Promotes Proliferation and Migration Through the Transcription Factor E2F1 in Cervical Cancer Cells

Mergers and acquisitions basics for the industrial electronics and communications industry [industry forum]

Upregulation of P18ink4c Expression by HPV E6 Via P53-Mir-34a Pathway